| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |